These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12174289)

  • 1. Use of Carcinoembryonic Antigen Gene Promoter in Colorectal Carcinoma-specific Suicidal Gene Therapy.
    Jiang Q; Ge K; Xu DH; Sun LY; Zheng ZC; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1998; 30(1):1-8. PubMed ID: 12174289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.
    Liu J; Zou WG; Lang MF; Luo J; Sun LY; Wang XN; Qian QJ; Liu XY
    Int J Oncol; 2002 Sep; 21(3):661-6. PubMed ID: 12168115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental treatment for human colorectal carcinoma by tissue type specific expression of herpes simplex virus thymidine kinase gene].
    Ge K; Jiang Q; Xu DH; Zheng ZC; Liu XY
    Shi Yan Sheng Wu Xue Bao; 1998 Sep; 31(3):259-64. PubMed ID: 12016970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
    Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
    Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy.
    Cao G; Kuriyama S; Cui L; Nagao S; Pan X; Toyokawa Y; Zhang X; Nishiwaki I; Qi Z
    Cancer Gene Ther; 1999; 6(6):572-80. PubMed ID: 10608354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH; Song Y; Ma DX; Qu X; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TSST-1 regulated synergistically by 5HRE and CEAp activates lymphocytes to kill CEA-positive tumor cells specifically].
    Tian Y; Sun XJ; Wang W; Wang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):525-9. PubMed ID: 20487641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.
    Richards CA; Austin EA; Huber BE
    Hum Gene Ther; 1995 Jul; 6(7):881-93. PubMed ID: 7578407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperthermia enhanced the killing effect of 5-fluorocytosine on human colon cancer cell line transfected with cytosine deaminase gene].
    Li JM; Li CJ; Lai DN; Wang XJ; He XL; Bao GQ; Wu T; Yin JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):234-7. PubMed ID: 16721685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer.
    Reinblatt M; Pin RH; Fong Y
    Surgery; 2004 Sep; 136(3):579-84. PubMed ID: 15349105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
    Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
    Deharvengt S; Wack S; Aprahamian M; Hajri A
    J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies in vitro on the alpha-fetoprotein-specific promoter mediated target gene therapy of hepatocellular carcinoma].
    Quan S; Pan G; Lu C; Liu D; Fang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):111-7. PubMed ID: 12569665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy.
    Mahan SD; Ireton GC; Knoeber C; Stoddard BL; Black ME
    Protein Eng Des Sel; 2004 Aug; 17(8):625-33. PubMed ID: 15381761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.